BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19632330)

  • 21. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.
    Lammich S; Buell D; Zilow S; Ludwig AK; Nuscher B; Lichtenthaler SF; Prinzen C; Fahrenholz F; Haass C
    J Biol Chem; 2010 May; 285(21):15753-60. PubMed ID: 20348102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sheddase ADAM10 is a potent modulator of prion disease.
    Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
    Elife; 2015 Feb; 4():. PubMed ID: 25654651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.
    Folgosa L; Zellner HB; El Shikh ME; Conrad DH
    J Immunol; 2013 Dec; 191(12):5951-8. PubMed ID: 24227779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha.
    Hikita A; Tanaka N; Yamane S; Ikeda Y; Furukawa H; Tohma S; Suzuki R; Tanaka S; Mitomi H; Fukui N
    Biochem Cell Biol; 2009 Aug; 87(4):581-93. PubMed ID: 19767822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
    Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
    J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ADAM10 deletion on Notch-1 signaling pathway and neuronal maintenance in adult mouse brain.
    Zhuang J; Wei Q; Lin Z; Zhou C
    Gene; 2015 Jan; 555(2):150-8. PubMed ID: 25445276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.
    Hooper NM
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):335-8. PubMed ID: 15787600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice.
    Schmitt U; Hiemke C; Fahrenholz F; Schroeder A
    Behav Brain Res; 2006 Dec; 175(2):278-84. PubMed ID: 17014917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.
    Prinzen C; Trümbach D; Wurst W; Endres K; Postina R; Fahrenholz F
    BMC Genomics; 2009 Feb; 10():66. PubMed ID: 19196476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
    Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
    FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein.
    Xu D; Sharma C; Hemler ME
    FASEB J; 2009 Nov; 23(11):3674-81. PubMed ID: 19587294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
    Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
    Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture.
    Chaimowitz NS; Martin RK; Cichy J; Gibb DR; Patil P; Kang DJ; Farnsworth J; Butcher EC; McCright B; Conrad DH
    J Immunol; 2011 Nov; 187(10):5114-22. PubMed ID: 21998451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
    Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
    Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis.
    Donners MM; Wolfs IM; Olieslagers S; Mohammadi-Motahhari Z; Tchaikovski V; Heeneman S; van Buul JD; Caolo V; Molin DG; Post MJ; Waltenberger J
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2188-95. PubMed ID: 20814017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases.
    Endres K; Postina R; Schroeder A; Mueller U; Fahrenholz F
    FEBS J; 2005 Nov; 272(22):5808-20. PubMed ID: 16279945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of retinal axons requires the metalloproteinase ADAM10.
    Chen YY; Hehr CL; Atkinson-Leadbeater K; Hocking JC; McFarlane S
    J Neurosci; 2007 Aug; 27(31):8448-56. PubMed ID: 17670992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System.
    Meyer zu Horste G; Derksen A; Stassart R; Szepanowski F; Thanos M; Stettner M; Boettcher C; Lehmann HC; Hartung HP; Kieseier BC
    J Neuropathol Exp Neurol; 2015 Nov; 74(11):1077-85. PubMed ID: 26426268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAM10 prodomain mutations cause late-onset Alzheimer's disease: not just the latest FAD.
    Vassar R
    Neuron; 2013 Oct; 80(2):250-3. PubMed ID: 24139026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.